ProfileGDS4718 / 230497_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 28% 25% 36% 30% 27% 36% 34% 32% 26% 22% 36% 22% 47% 47% 27% 27% 37% 28% 42% 33% 28% 31% 33% 26% 25% 41% 31% 27% 24% 44% 26% 33% 25% 26% 27% 32% 67% 31% 24% 49% 27% 60% 31% 32% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4708428
GSM549102patient 115, normal, homogenized [OPG study]4.3494125
GSM549104patient 119, normal, homogenized [OPG study]4.7813736
GSM549108patient 138, normal, homogenized [OPG study]4.5947930
GSM549119patient 077, normal, homogenized [OPG study]4.429427
GSM549133patient 032, cancer, homogenized [OPG study]4.7608936
GSM549139patient 042, cancer, homogenized [OPG study]4.7127334
GSM549099patient 107, normal, homogenized [OPG study]4.6389132
GSM549109patient 139, normal, homogenized [OPG study]4.4024326
GSM549110patient 046, normal, homogenized [OPG study]4.2168322
GSM549114patient 063, normal, homogenized [OPG study]4.7721836
GSM549122patient 082, normal, homogenized [OPG study]4.241422
GSM549134patient 033, cancer, homogenized [OPG study]5.3515147
GSM549136patient 036, cancer, homogenized [OPG study]5.2996847
GSM549140patient 044, cancer, homogenized [OPG study]4.3875627
GSM549111patient 047, normal, homogenized [OPG study]4.3794927
GSM549113patient 057, normal, homogenized [OPG study]4.7903737
GSM549132patient 031, cancer, homogenized [OPG study]4.4366828
GSM549137patient 038, cancer, homogenized [OPG study]5.0717242
GSM549142patient 047, cancer, homogenized [OPG study]4.7755833
GSM549100patient 110, normal, homogenized [OPG study]4.4884128
GSM549107patient 135, normal, homogenized [OPG study]4.5696231
GSM549115patient 068, normal, homogenized [OPG study]4.6127933
GSM549116patient 072, normal, homogenized [OPG study]4.3407726
GSM549120patient 078, normal, homogenized [OPG study]4.349725
GSM549131patient 030, cancer, homogenized [OPG study]4.9940341
GSM549118patient 074, normal, homogenized [OPG study]4.5767731
GSM549129patient 027, cancer, homogenized [OPG study]4.4244527
GSM549123patient 088, normal, homogenized [OPG study]4.2930324
GSM549124patient 006, cancer, homogenized [OPG study]5.2226544
GSM549126patient 015, cancer, homogenized [OPG study]4.3540926
GSM549128patient 025, cancer, homogenized [OPG study]4.6316133
GSM549103patient 117, normal, homogenized [OPG study]4.3824525
GSM549117patient 073, normal, homogenized [OPG study]4.335126
GSM549138patient 041, cancer, homogenized [OPG study]4.3824527
GSM549141patient 045, cancer, homogenized [OPG study]4.5496432
GSM549130patient 028, cancer, homogenized [OPG study]6.6211967
GSM549101patient 111, normal, homogenized [OPG study]4.6161631
GSM549105patient 128, normal, homogenized [OPG study]4.3205624
GSM549106patient 134, normal, homogenized [OPG study]5.4192849
GSM549112patient 048, normal, homogenized [OPG study]4.4279227
GSM549125patient 011, cancer, homogenized [OPG study]6.1335660
GSM549127patient 024, cancer, homogenized [OPG study]4.5614131
GSM549135patient 035, cancer, homogenized [OPG study]4.5709532